Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs, an AI drug-discovery platform spun out of Google DeepMind in 2021, has raised $5 billion in Series C funding. The capital will accelerate the company's pipeline of drug candidates toward clinical trials.
Why it matters
The massive funding round demonstrates investor confidence in AI-driven drug discovery and brings computational approaches to pharmaceutical development closer to real-world testing.
More on:Google DeepMind
Coverage
- via TechmemeAlphabet's Isomorphic Labs raised a $5B Series C led by Sequoia and Greenoaks, after raising $2.1B in May and $600M in March 2025, to accelerate clinical trials (Bloomberg)
- TechCrunchIsomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
- The DecoderIsomorphic Labs raises $5 billion in its second mega-round within six months


